Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2016 May 5;12(8):2188–2196. doi: 10.1080/21645515.2016.1165374

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© 2016 Merck Sharp & Dohme Corp., a subsidiary of Merck & Co., Inc., Kenilworth, N.J., U.S.A.

PMC Copyright notice

Figure 1. — Subject disposition. ^aNumber of subjects excluded from the per-protocol MMRV_AMP postdose 1 immunogenicity analyses: Measles (69); Mumps (80); Rubella (90); and Varicella (112). ^bNumber of subjects excluded from the per-protocol MMRV postdose 1 immunogenicity analyses: Measles (81); Mumps (92); Rubella (109); and Varicella (114). ^cOne subject did not receive Dose 2, but was followed for 180 d postdose 1 and discontinued due to an AE (onset was Day 5 postdose 1) during the extended safety follow-up but before study completion.